| About the author: |
Bilovol O.M., Kniazkova I.I., Bohun M.V., Kuzminova N.V., Osovska N.Y. |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The purpose of the work was to study the effect of fixed combination of meldonium dihydrate and γ-butyrobetaine dihydrate (MD+γ-BD) on clinical, hemodynamic and glucometabolic parameters, as well as indicators of oxidant-antioxidant status in patients (pts) with heart failure (HF) and type 2 diabetes mellitus (DM). The total of 62 patients with HF and DM were examined. After registration of the baseline data, baseline therapy was prescribed to all patients, 30 of them (group 1) obtained an additional fixed combination of MD+γ-BD 2 capsules three times a day for 3 months and 32 patients were included in the comparison group (group 2). After treatment in group 1, the increase of the distance walked was determined according to the 6-minute walk test by 31.2% versus 12.7% in group 2 (p <0.05). There was an increase in left ventricular (LV) ejection fraction by 4.5% in group 1 versus 1.9% in group 2 (p <0.05). Positive changes in glucometabolic parameters were observed. A decrease of the activity of lipid peroxidation processes according to the level of malondialdehyde (Δ-22.3% in patients of group 1 versus Δ-11.2% in group 2, p <0.05) and an increase in the activity of erythrocyte superoxide dismutase (respectively Δ29.5% vs. 8.1%, p <0.05) were found. Thus, an addition of a fixed combination of MD+γ-BD in the complex therapy of pts with HF and type 2 DM improves clinical symptoms in patients, has a positive effect on the structural and functional parameters of the left ventricle, glucometabolic parameters and imbalance of the oxidant-antioxidant system by increasing the activity of intracellular antioxidant enzymes. |
| Tags |
heart failure, type 2 diabetes mellitus, structural and functional changes of the left ventricle, lipid peroxidation, fixed combination of meldonium dihydrate and γ-butyrobetaine dihydrate |
| Bibliography |
- Bilovol AN, Kniazkova I.I. Metabolic therapy for coronary heart disease in the elderly. Medicines of Ukraine. 2012; 5:51-55. [in Ukrainian]
- Voronkov LG Patient with CHF in Ukraine: analysis of patient population examined in the framework of the first national UNIVERS section trial. Heart failure. 2012; 2:6-13 [in Ukrainian]
- Bellou V, Belbasis L, Tzoulaki I, Evangelou E. Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses. PLoS One. 2018 Mar 20;13(3):e0194127.
- Berliner D, Bauersachs J. Drug treatment of heart failure in the elderly. Herz. 2018 May; 43(3):207-213.
- Dambrova M, Makrecka-Kuka M, Vilskersts R, Makarova E, Kuka J, Liepinsh E. Pharmacological effects of meldonium: Biochemical mechanisms and biomarkers of cardiometabolic activity. Pharmacol Res. 2016 Nov; 113(Pt B):771-780.
- Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, et al. Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. J Card Fail. 2019 Aug;25(8):584-619.
- Fukushima A, Milner K, Gupta A, Lopaschuk GD. Myocardial Energy Substrate Metabolism in Heart Failure: from Pathways to Therapeutic Targets. Curr Pharm Des. 2015;21(25):3654-64.
- Makrecka-Kuka M, Liepinsh E, Murray AJ, Lemieux H, Dambrova M, Tepp K, et al. Altered mitochondrial metabolism in the insulin-resistant heart. Acta Physiol (Oxf). 2019 Dec 16:e13430
- Roberts PA, Bouitbir J, Bonifacio A, Singh F, Kaufmann P, Urwyler A. Contractile function and energy metabolism of skeletal muscle in rats with secondary carnitine deficiency. Krähenbühl S. Am J Physiol Endocrinol Metab. 2015 Aug 1; 309(3):E265-74.
- Rosano GMC, Vitale C, Seferovic P. Heart failure in patients with diabetes mellitus. Card Fail Rev. 2017;3:52–5.
- Sokolovska J, Isajevs S, Rostoka E, Sjakste T, Trapiņa I, Ošiņa K, Paramonova N, Sjakste N. Changes in glucose transporter expression and nitric oxide production are associated with liver injury in diabetes. Cell Biochem Funct. 2015 Aug;33(6):367-74
- Tarp J, Støle AP, Blond K, Grøntved A. Cardiorespiratory fitness, muscular strength and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetologia. 2019 Jul;62(7):1129-1142.
- Valentina R, Weiss MC, Weintraub H, Goldberg IJ, Schwartzbard A. Cardiovascular disease leads to a new algorithm for diabetes treatment. J Clin Lipidol. 2017; 11:1126–33.
|
| Publication of the article |
«World of Medicine and Biology» №1(71), 2020 year, 018-022 pages, index UDK 616.12-008.46-085:616.379-008.64 |
| DOI |
10.26724/2079-8334-2020-1-71-18-22 |
